Westscheme has invested up to $16.9 million in early-stage commercial technology.
Government superannuation fund Westscheme has invested up to $16.9 million in early-stage commercial technology.
The investments were made through three private equity funds. The fund committed $15.6 million to the Medical Research Commercialisation Fund, $800,000 to Xerocoat co-investment and US$500,000 ($580,000) to Fultec co-investment.
"Westscheme has been investing in early-stage research since 2001. We have a number of commercial arrangements with universities to develop their technologies. These investments will support the next phase of their technology and research development," Westscheme chief executive Howard Rosario said.
Westscheme has joint ventures with Murdoch University and Uniseed. Uniseed is a joint venture between Queensland and Melbourne universities to help source deals.
The $2.8 billion fund has about $156 million committed to early-stage research. The fund has also made changes to its collateralised debt obligation (CDO) portfolio.
Westscheme invested US$6.56 million ($7.59 million) in Tourmaline CDO III and redeemed its investment in the Greenwich Street Capital V collateralised debt obligation.
In Part 2 of our exclusive series, we ask leading names to nominate their best investments, the most effective industry group and the importance of platforms.
Advance appoints two, hikes fees »
St George Bank's funds management arm, Advance Asset Management, has appointed global property trusts CB Richard Ellis and European Investors to its manager line-up and terminated one of its two domestic managers.
Nestle, CSR, Rinker hire Russell »
Three of Australia's biggest companies have hired Russell Investment Group to run their superannuation accounts.
A complaint by a reader about our reporting of two Sydney planners facing jail made us do a little research on the subject of who can be called a planner.... read more »
